Todd R. Brady
Director · Contineum Therapeutics, Inc.
Individual
- 2026
- Jun 26, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Todd R. Brady files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Daniel S. Lorrain - $1.04M in CTNM purchases and sales in the last 12 months
- Carmine N. Stengone - $401K in CTNM purchases and sales in the last 12 months
- Tim Watkins - $279K in CTNM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Todd R. Brady?
Todd R. Brady is a corporate insider, tracked as Director of Contineum Therapeutics, Inc. (CTNM). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Todd R. Brady last file a Form 4?
The only primary Form 4 on record is dated 26 June 2026.